These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20017910)

  • 61. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.
    Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M
    J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
    Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
    Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
    Athyros VG; Papageorgiou AA; Athyrou VV; Demitriadis DS; Kontopoulos AG
    Diabetes Care; 2002 Jul; 25(7):1198-202. PubMed ID: 12087019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in action of atorvastatin and ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function: randomized controlled trial.
    Matsue Y; Matsumura A; Suzuki M; Hashimoto Y; Yoshida M
    Circ J; 2013; 77(7):1791-8. PubMed ID: 23603824
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Statin-ezetimibe combination in hyperlipidemia treatment].
    Vareka T; Vítková D; Zeman M; Vecka M; Zák A
    Cas Lek Cesk; 2012; 151(1):17-21. PubMed ID: 22442891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.
    Okada K; Kimura K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S
    Circ J; 2011; 75(10):2496-504. PubMed ID: 21817821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease.
    Cruz-Fernández JM; Bedarida GV; Adgey J; Allen C; Johnson-Levonas AO; Massaad R
    Int J Clin Pract; 2005 Jun; 59(6):619-27. PubMed ID: 15924587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
    Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
    Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
    Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada.
    Kohli M; Attard C; Lam A; Huse D; Cook J; Bourgault C; Alemao E; Yin D; Marentette M
    Pharmacoeconomics; 2006; 24(8):815-30. PubMed ID: 16898850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
    Kei A; Tellis C; Liberopoulos E; Tselepis A; Elisaf M
    Cardiovasc Ther; 2014 Aug; 32(4):139-46. PubMed ID: 24618208
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?
    Husain NE; Hassan AT; Elmadhoun WM; Ahmed MH
    Expert Opin Drug Saf; 2015; 14(9):1445-55. PubMed ID: 26134926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
    Nissen SE; Nicholls SJ; Wolski K; Howey DC; McErlean E; Wang MD; Gomez EV; Russo JM
    JAMA; 2007 Mar; 297(12):1362-73. PubMed ID: 17384435
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia.
    Lipka L; Sager P; Strony J; Yang B; Suresh R; Veltri E;
    Drugs Aging; 2004; 21(15):1025-32. PubMed ID: 15631531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
    Jones PH; Bays HE; Davidson MH; Kelly MT; Buttler SM; Setze CM; Sleep DJ; Stolzenbach JC
    Clin Drug Investig; 2008; 28(10):625-34. PubMed ID: 18783301
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination of a sterol absorption inhibitor and cardiovascular agents for the treatment of dyslipidemia.
    Chrysohoou C; Singh S
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):73-8. PubMed ID: 18221076
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors.
    Makkar KM; Sanoski CA; Goldberg LR; Spinler SA
    Ann Pharmacother; 2013 Nov; 47(11):1457-62. PubMed ID: 24285762
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
    Simons LA
    Aust N Z J Med; 1998 Jun; 28(3):327-33. PubMed ID: 9673745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.